Charles Lowney
Family Medicine · Hyde Park, MANPI 1982775185
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 440 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,177 and has fallen 99.3% since, to $22 in 2025. Among family medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 440 payments — averaging $24.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$1K
- AbbVie$944
- Amgen$887
- Lilly USA, LLC$590
- E.r. Squibb & Sons, L.L.C.$584
- plus $5K from 31 others
What the payments were for
- Food & beverage$10,699100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 64 | $1,660 |
| Novo Nordisk | 51 | $1,443 |
| AbbVie(2 entities) | 44 | $944 |
| Amgen | 25 | $887 |
| Lilly USA, LLC | 38 | $590 |
| E.r. Squibb & Sons, L.L.C. | 19 | $584 |
| Pfizer | 29 | $571 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 28 | $542 |
| Astellas Pharma US Inc | 14 | $387 |
| Johnson & Johnson | 15 | $358 |
| Neurocrine Biosciences, Inc. | 8 | $342 |
| Novartis | 16 | $334 |
| Boehringer Ingelheim | 15 | $284 |
| GSK | 9 | $213 |
| Bayer | 5 | $186 |
| Nestle Healthcare Nutrition Inc. | 5 | $175 |
| Merck | 10 | $168 |
| Amarin Pharma, Inc. | 2 | $156 |
| Bristol Myers Squibb | 5 | $110 |
| Sanofi-aventis U.S. LLC | 5 | $90 |
| VBI Vaccine (delaware) Inc. | 3 | $78 |
| Esperion Therapeutics, Inc. | 2 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Exact Sciences | 3 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $56 |
| QOL Medical, LLC | 2 | $51 |
| Biogen | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 3 | $44 |
| Antares Pharma, Inc. | 2 | $38 |
| Dermira, Inc. | 2 | $30 |
| Eisai Inc. | 1 | $30 |
| Medtronic | 1 | $25 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,708 in reported general payments places this provider in the 95th percentile of 1,049 family medicine providers in Massachusetts.
Other family medicine in Hyde Park
- Jeremiah LowneyHyde Park$17K
- Larry CulpepperBoston$109K
- Jennifer WeylerWorcester$105K
- Megan McCoyFramingham$75K
- Kristina GraceyWorcester$73K
- Suzanne MitchellBoston$69K
- John GrievesonLowell$24K
- James SalemisRoslindale$24K
- David FarzanLawrence$23K
- Julie JohnstonLawrence$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.